Financing ·
On June 26, 2026, Beneficient entered into an amended and restated Standby Equity Purchase Agreement (A&R SEPA) with…
BENFBeneficient
On June 26, 2026, Beneficient entered into an amended and restated Standby Equity Purchase Agreement (A&R SEPA) with YA II PN, Ltd. (Yorkville), granting the company the right to sell up to $100.0 million of Class A common stock. As part of this agreement, Yorkville will advance $4.0 million via convertible promissory notes. On June 30, 2026, the company issued the first $2.0 million promissory note, receiving approximately $1.8 million in gross proceeds after a 5% original issue discount. The note matures on June 30, 2027, bears 5.0% interest, and is convertible into Class A common stock at a price based on the lower of $5.6064 or 92.0% of the lowest daily VWAP of the five trading days prior to conversion, with a floor price of $0.89. Beneficient provides healthcare-related financial services and technology.